CHAPEL HILL, N.C.--(BUSINESS WIRE)--May 29, 2003--POZEN Inc.
(Nasdaq: POZN) announced today that John R. Plachetka, Pharm.D., the
company's chairman, president and chief executive officer, will be
speaking to investors at the Needham & Company Second Annual
Biotechnology Conference on Friday, June 6, at 10:00 a.m. Eastern
Dr. Plachetka will provide an overview of POZEN's business.
The presentation will be webcast live and archived on POZEN's home
page at www.pozen.com.
POZEN is a pharmaceutical company developing therapeutic
advancements in a cost effective manner. Since its inception, POZEN
has developed the largest and most advanced product pipeline in the
field of migraine. Product development efforts are focused on diseases
with unmet needs and where POZEN can improve efficacy, safety, and/or
patient convenience. The company's common stock is traded on The
Nasdaq Stock Market under the symbol "POZN." For detailed company
information, see POZEN's website: www.pozen.com.
Chief Financial Officer
Director, Investor Relations